<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31300658</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.</ArticleTitle><Pagination><StartPage>10080</StartPage><MedlinePgn>10080</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10080</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-46227-3</ELocationID><Abstract><AbstractText>Coxsackieviruses B (CV-B) belong to the EV-B species. CV-B and particularly CV-B4 are thought to be involved in the development of chronic diseases like type 1 diabetes (T1D). The mechanisms of the enteroviral pathogenesis of T1D are not well known, yet. The in vitro studies are rich with information but in vivo infection models are needed to investigate the impact of viruses onto organs. Our objective was to study the impact of CV-B4E2 combined with a single sub-diabetogenic dose of streptozotocin (STZ) on the pancreas of mice. The infection with CV-B4E2 of CD1 outbred mice treated with a sub-diabetogenic dose of STZ induced hyperglycemia and hypoinsulinemia. Along with the chemokine IP-10, viral RNA and infectious particles were detected in the pancreas. The pancreas of these animals was also marked with insulitis and other histological alterations. The model combining STZ and CV-B4E2 opens the door to new perspectives to better understand the interactions between virus and host, and the role of environmental factors capable, like STZ, to predispose the host to the diabetogenic effects of enteroviruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benkahla</LastName><ForeName>Mehdi A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sane</LastName><ForeName>Famara</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertin</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vreulx</LastName><ForeName>Anais-Camille</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmastour</LastName><ForeName>Firas</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaidane</LastName><ForeName>Hela</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Monastir, Facult&#xe9; de Pharmacie, Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives LR99ES27, Monastir, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Tunis El Manar, Facult&#xe9; des Sciences de Tunis, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desailloud</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Picardie Jules Verne, CHU d'Amiens, Service d'Endocrinologie-Diab&#xe9;tologie-Nutrition, F-80054, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hober</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lille, Facult&#xe9; de M&#xe9;decine, CHU de Lille, Laboratoire de Virologie/EA3610, F-59037, Lille, France. didier.hober@chru-lille.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054357">Chemokine CXCL10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485433">Cxcl10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>5W494URQ81</RegistryNumber><NameOfSubstance UI="D013311">Streptozocin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054357" MajorTopicYN="N">Chemokine CXCL10</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013311" MajorTopicYN="N">Streptozocin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31300658</ArticleId><ArticleId IdType="pmc">PMC6626040</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-46227-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-46227-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hober D, et al. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin. Exp. Immunol. 2012;168:47&#x2013;51. doi: 10.1111/j.1365-2249.2011.04559.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04559.x</ArticleId><ArticleId IdType="pmc">PMC3390492</ArticleId><ArticleId IdType="pubmed">22385236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013;14:282&#x2013;293. doi: 10.1016/j.meegid.2012.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol. 2010;6:279&#x2013;289. doi: 10.1038/nrendo.2010.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2010.27</ArticleId><ArticleId IdType="pubmed">20351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hy&#xf6;ty H. Viruses in type 1 diabetes. Pediatr Diabetes. 2016;17(Suppl 22):56&#x2013;64. doi: 10.1111/pedi.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12370</ArticleId><ArticleId IdType="pubmed">27411438</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69&#x2013;82. doi: 10.1016/S0140-6736(13)60591-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60591-7</ArticleId><ArticleId IdType="pmc">PMC4380133</ArticleId><ArticleId IdType="pubmed">23890997</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer MJ, Lavall&#xe9;e DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS ONE. 2009;4:e4127. doi: 10.1371/journal.pone.0004127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004127</ArticleId><ArticleId IdType="pmc">PMC2606033</ArticleId><ArticleId IdType="pubmed">19122812</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805&#x2013;820. doi: 10.1016/j.cell.2010.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota S, Okabayashi T, Fujii N. The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection. Mediators Inflamm. 2010;2010:e184328. doi: 10.1155/2010/184328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/184328</ArticleId><ArticleId IdType="pmc">PMC2903949</ArticleId><ArticleId IdType="pubmed">20672047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816&#x2013;825. doi: 10.1038/sj.cdd.4401850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401850</ArticleId><ArticleId IdType="pubmed">16410796</ArticleId></ArticleIdList></Reference><Reference><Citation>Frigerio S, et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 2002;8:1414&#x2013;1420. doi: 10.1038/nm1202-792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1202-792</ArticleId><ArticleId IdType="pubmed">12415259</ArticleId></ArticleIdList></Reference><Reference><Citation>Roep BO, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin. Exp. Immunol. 2010;159:338&#x2013;343. doi: 10.1111/j.1365-2249.2009.04087.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2009.04087.x</ArticleId><ArticleId IdType="pmc">PMC2819499</ArticleId><ArticleId IdType="pubmed">20059481</ArticleId></ArticleIdList></Reference><Reference><Citation>Uno S, et al. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes. Endocr. J. 2010;57:991&#x2013;996. doi: 10.1507/endocrj.K10E-076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.K10E-076</ArticleId><ArticleId IdType="pubmed">20966598</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz E, et al. &#x3b2;-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes. Diabetes. 2018;67:2305&#x2013;2318. doi: 10.2337/db17-1006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db17-1006</ArticleId><ArticleId IdType="pmc">PMC6198335</ArticleId><ArticleId IdType="pubmed">30150306</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin AP, et al. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J. Immunol. 2007;178:4623&#x2013;4631. doi: 10.4049/jimmunol.178.7.4623.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.7.4623</ArticleId><ArticleId IdType="pubmed">17372021</ArticleId></ArticleIdList></Reference><Reference><Citation>King AJF. The use of animal models in diabetes research. Br. J. Pharmacol. 2012;166:877&#x2013;894. doi: 10.1111/j.1476-5381.2012.01911.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01911.x</ArticleId><ArticleId IdType="pmc">PMC3417415</ArticleId><ArticleId IdType="pubmed">22352879</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham ML, Schuurman H-J. Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research. Eur. J. Pharmacol. 2015;759:221&#x2013;230. doi: 10.1016/j.ejphar.2015.02.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.02.054</ArticleId><ArticleId IdType="pubmed">25814249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane H, et al. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab. Res. Rev. 2009;25:591&#x2013;603. doi: 10.1002/dmrr.995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.995</ArticleId><ArticleId IdType="pubmed">19621354</ArticleId></ArticleIdList></Reference><Reference><Citation>Herr RR, Jahnke JK, Argoudelis AD. The structure of streptozotocin. J. Am. Chem. Soc. 1967;89:4808&#x2013;4809. doi: 10.1021/ja00994a053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja00994a053</ArticleId><ArticleId IdType="pubmed">6074800</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000;43:1528&#x2013;1533. doi: 10.1007/s001250051564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250051564</ArticleId><ArticleId IdType="pubmed">11151762</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto H, Takasawa S. Recent advances in physiological and pathological significance of NAD+ metabolites: roles of poly(ADP-ribose) and cyclic ADP-ribose in insulin secretion and diabetogenesis. Nutr Res Rev. 2003;16:253&#x2013;266. doi: 10.1079/NRR200362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/NRR200362</ArticleId><ArticleId IdType="pubmed">19087393</ArticleId></ArticleIdList></Reference><Reference><Citation>Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest. 1969;48:2129&#x2013;2139. doi: 10.1172/JCI106180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI106180</ArticleId><ArticleId IdType="pmc">PMC297467</ArticleId><ArticleId IdType="pubmed">4241908</ArticleId></ArticleIdList></Reference><Reference><Citation>Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 1976;193:415&#x2013;417. doi: 10.1126/science.180605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.180605</ArticleId><ArticleId IdType="pubmed">180605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J. 1994;8:529&#x2013;533. doi: 10.1096/fasebj.8.8.8181671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.8.8.8181671</ArticleId><ArticleId IdType="pubmed">8181671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H. Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes. 1988;37:21&#x2013;27. doi: 10.2337/diab.37.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.37.1.21</ArticleId><ArticleId IdType="pubmed">3275555</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo A, Onodera T, Yoon JW, Notkins AL. Induction of diabetes by cumulative environmental insults from viruses and chemicals. Nature. 1980;288:383&#x2013;385. doi: 10.1038/288383a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/288383a0</ArticleId><ArticleId IdType="pubmed">6253833</ArticleId></ArticleIdList></Reference><Reference><Citation>Precechtelova J, et al. Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2. Arch. Virol. 2015;160:103&#x2013;115. doi: 10.1007/s00705-014-2236-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2236-7</ArticleId><ArticleId IdType="pubmed">25293347</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology. 2003;314:510&#x2013;520. doi: 10.1016/S0042-6822(03)00462-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00462-8</ArticleId><ArticleId IdType="pubmed">14554080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera SM, Henschel AM, Hessner MJ. Innate inflammation in type 1 diabetes. Transl Res. 2016;167:214&#x2013;227. doi: 10.1016/j.trsl.2015.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2015.04.011</ArticleId><ArticleId IdType="pmc">PMC4626442</ArticleId><ArticleId IdType="pubmed">25980926</ArticleId></ArticleIdList></Reference><Reference><Citation>McDuffie E, Obert L, Chupka J, Sigler R. Detection of cytokine protein expression in mouse lung homogenates using suspension bead array. J Inflamm. 2006;3:15. doi: 10.1186/1476-9255-3-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-3-15</ArticleId><ArticleId IdType="pmc">PMC1681346</ArticleId><ArticleId IdType="pubmed">17134510</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisk G, Grapengiesser E, Diderholm H. Impaired Ca2+ response to glucose in mouse beta-cells infected with coxsackie B or Echo virus. Virus Res. 1994;33:229&#x2013;240. doi: 10.1016/0168-1702(94)90105-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(94)90105-8</ArticleId><ArticleId IdType="pubmed">7985410</ArticleId></ArticleIdList></Reference><Reference><Citation>Flodstr&#xf6;m M, et al. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 2002;3:373&#x2013;382. doi: 10.1038/ni771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni771</ArticleId><ArticleId IdType="pubmed">11919579</ArticleId></ArticleIdList></Reference><Reference><Citation>Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology. 2004;329:381&#x2013;394. doi: 10.1016/j.virol.2004.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.06.049</ArticleId><ArticleId IdType="pubmed">15518817</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli A, et al. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272&#x2013;280. doi: 10.1016/j.autrev.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.10.010</ArticleId><ArticleId IdType="pubmed">24189283</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H, et al. The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells. Int. J. Mol. Med. 2017;40:182&#x2013;192. doi: 10.3892/ijmm.2017.3008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3008</ArticleId><ArticleId IdType="pmc">PMC5466389</ArticleId><ArticleId IdType="pubmed">28560385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo Y-M, Park YC. Streptozotocin-Induced Autophagy Reduces Intracellular Insulin in Insulinoma INS-1E Cells. DNA and Cell Biology. 2018;37:160&#x2013;167. doi: 10.1089/dna.2017.3874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2017.3874</ArticleId><ArticleId IdType="pubmed">29485914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009;58:2285&#x2013;2291. doi: 10.2337/db09-0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-0091</ArticleId><ArticleId IdType="pmc">PMC2750208</ArticleId><ArticleId IdType="pubmed">19641142</ArticleId></ArticleIdList></Reference><Reference><Citation>Aida K, et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes. 2011;60:884&#x2013;889. doi: 10.2337/db10-0795.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-0795</ArticleId><ArticleId IdType="pmc">PMC3046849</ArticleId><ArticleId IdType="pubmed">21289206</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeds MC, et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 2011;45:131&#x2013;140. doi: 10.1258/la.2010.010090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/la.2010.010090</ArticleId><ArticleId IdType="pmc">PMC3917305</ArticleId><ArticleId IdType="pubmed">21478271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane Hela, Gharbi Jawhar, Lobert Pierre-Emmanuel, Caloone Delphine, Lucas Bernadette, San&#xe9; Famara, Idziorek Thierry, Romond Marie-B&#xe9;n&#xe9;dicte, Aouni Mahjoub, Hober Didier. Infection of primary cultures of murine splenic and thymic cells with coxsackievirus B4. Microbiology and Immunology. 2008;52(1):40&#x2013;46. doi: 10.1111/j.1348-0421.2008.00002.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2008.00002.x</ArticleId><ArticleId IdType="pubmed">18352912</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmastour F, et al. Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system. Virulence. 2016;7:527&#x2013;535. doi: 10.1080/21505594.2016.1152442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2016.1152442</ArticleId><ArticleId IdType="pmc">PMC5026789</ArticleId><ArticleId IdType="pubmed">27030584</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou EK, San&#xe9; F, Engelmann I, Hober D. Serum-dependent enhancement of coxsackievirus B4-induced production of IFN&#x3b1;, IL-6 and TNF&#x3b1; by peripheral blood mononuclear cells. J. Mol. Biol. 2013;425:5020&#x2013;5031. doi: 10.1016/j.jmb.2013.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.10.008</ArticleId><ArticleId IdType="pubmed">24120940</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>